A new wave of Lipitor diabetes injury lawsuits has been filed against Pfizer, Inc. over its failure to warn consumers about the risks of developing Type 2 diabetes when taking the company’s cholesterol reducing drug Lipitor (atorvastatin). Although Pfizer has said that adding a black box warning to the drug in 2012 was sufficient, lawsuits […]
Lipitor (atorvastatin), Pfizer’s best selling cholesterol drug, was approved by the U.S. Food & Drug Administration (FDA) in 1996 and quickly became one of the company’s best-selling drugs. Lipitor has generated over $125 billion in sales for Pfizer. However, it is now being linked to type 2 diabetes in women over 50. What Is Diabetes? […]
A growing number of women over the age of 50 are claiming that they developed Type II diabetes after taking Pfizer Inc.’s cholesterol drug Lipitor. They allege that Pfizer knew that Lipitor increased their risk of developing diabetes, but failed to warn them. Several lawsuits have already been filed against Pfizer, and plaintiffs are now […]
Pfizer’s best-selling cholesterol drug, Lipitor, has generated over $125 billion in sales – partially due to the company’s advertisements touting a healthy lifestyle. However, Lipitor may not be so beneficial for women over 50 years old, as studies have shown that it increases their risk of developing Type II diabetes. Study Shows Lipitor May Increase […]